These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 421730)

  • 1. Alterations of phenytoin protein binding with in vivo haemodialysis in dialysis encephalopathy.
    Steele WH; Lawrence JR; Elliott HL; Whiting B
    Eur J Clin Pharmacol; 1979 Feb; 15(1):69-71. PubMed ID: 421730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine and phenytoin binding to plasma proteins in renal and hepatic failure.
    Olsen GD; Bennett WM; Porter GA
    Clin Pharmacol Ther; 1975 Jun; 17(6):677-84. PubMed ID: 1095281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EMIT FreeLevel ultrafiltration technique compared with equilibrium dialysis and ultracentrifugation to determine protein binding of phenytoin.
    Oellerich M; Müller-Vahl H
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():61-70. PubMed ID: 6705428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased free phenytoin concentrations in predialysis serum compared to postdialysis serum in patients with uremia treated with hemodialysis. Role of uremic compounds.
    Dasgupta A; Abu-Alfa A
    Am J Clin Pathol; 1992 Jul; 98(1):19-25. PubMed ID: 1615921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma protein binding interaction between phenytoin and valproic acid in vitro.
    Monks A; Boobis S; Wadsworth J; Richens A
    Br J Clin Pharmacol; 1978 Dec; 6(6):487-92. PubMed ID: 365209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the serum protein binding of maprotiline and phenytoin in uraemic patients on haemodialysis.
    Lynn K; Braithwaite R; Dawling S; Rosser R
    Eur J Clin Pharmacol; 1981 Jan; 19(1):73-7. PubMed ID: 7461027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of temperature on serum protein binding characteristics of phenytoin in monotherapy paediatric patients with epilepsy.
    Kodama H; Kodama Y; Itokazu N; Shinozawa S; Kanemaru R; Sugimoto T
    J Clin Pharm Ther; 2001 Jun; 26(3):175-9. PubMed ID: 11422600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo binding characteristics of phenytoin to serum proteins in monotherapy for adults with epilepsy.
    Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
    Am J Ther; 2000 Nov; 7(6):359-63. PubMed ID: 11304643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.
    Odar-Cederlöf I; Borga O
    Clin Pharmacol Ther; 1976 Jul; 20(1):36-47. PubMed ID: 1277724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protein binding of methotrexate by the serum of normal subjects.
    Steele WH; Lawrence JR; Stuart JF; McNeill CA
    Eur J Clin Pharmacol; 1979 Jun; 15(5):363-6. PubMed ID: 456408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperature effect on serum protein binding kinetics of phenytoin in monotherapy patients with epilepsy.
    Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
    Eur J Pharm Biopharm; 1999 May; 47(3):295-8. PubMed ID: 10382115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein binding of digitoxin, valproate and phenytoin in sera from diabetics.
    Doucet J; Fresel J; Hue G; Moore N
    Eur J Clin Pharmacol; 1993; 45(6):577-9. PubMed ID: 8157046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum protein binding kinetics of phenytoin in monotherapy patients.
    Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
    J Clin Pharm Ther; 1998 Oct; 23(5):361-5. PubMed ID: 9875684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma protein binding of phenytoin and warfarin in patients undergoing renal transplantation.
    Odar-Cederlof I
    Clin Pharmacokinet; 1977; 2(2):147-53. PubMed ID: 324689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of chronic renal failure and hemodialysis on diflunisal plasma protein binding.
    Verbeeck RK; De Schepper PJ
    Clin Pharmacol Ther; 1980 May; 27(5):628-35. PubMed ID: 7371361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal function and therapeutic concentrations of phenytoin.
    Liponi DF; Winter ME; Tozer TN
    Neurology; 1984 Mar; 34(3):395-7. PubMed ID: 6538287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo binding characteristics of phenytoin to serum proteins in monotherapy pediatric patients with epilepsy.
    Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Itokazu N; Sugimoto T
    Int J Clin Pharmacol Ther; 2000 Jan; 38(1):25-9. PubMed ID: 10667833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of temperature on binding characteristics of phenytoin to serum proteins in monotherapy adult patients with epilepsy.
    Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
    Am J Ther; 2000 Jan; 7(1):11-5. PubMed ID: 11319568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
    Nishio T; Takamura N; Nishii R; Tokunaga J; Yoshimoto M; Kawai K
    Nephrol Dial Transplant; 2008 Jul; 23(7):2304-10. PubMed ID: 18390890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.